Information Provided By: 
Fly News Breaks for February 8, 2019
ALNY
Feb 8, 2019 | 08:26 EDT
BMO Capital analyst Do Kim lowered his price target on Alnylam to $106 after its better than expected Q4 results but higher assumptions for operating expenses. The analyst also keeps his Outperform rating on the stock based on his view that "U.S. Onpattro launch has enough momentum, given start form metrics and patient identification through genetic testing".
News For ALNY From the Last 2 Days
ALNY
Apr 23, 2024 | 07:17 EDT
ProQR Therapeutics (PRQR) announced the Annual General Meeting, AGM, of Shareholders will take place on Wednesday, May 22, 2024 at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands. As part of the AGM, Martin Maier, PhD, is nominated for appointment as a non-executive Board Member for a period of four years. Dr. Maier is Senior Vice President Research heading the Oncology group at Alnylam Pharmaceuticals (ALNY).
